Therapy Areas: Devices
Implantica produces 10,000 RefluxStop units ahead of planned US launch
10 September 2025 - Medical technology company Implantica AG (Nasdaq First North Premier Growth Market: IMP A SDB) reported on Wednesday that it is ramping up production of its RefluxStop device with ...
Elute partners Spartan Medical
10 September 2025 - Elute Inc, a US-based developer of drug-eluting device technology for controlled and extended drug release, on Tuesday announced a strategic partnership with Spartan Medical Inc, a...
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD
9 September 2025 - Saol Therapeutics, a US-based clinical-stage pharmaceutical company, announced on Monday that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) r...
Abbott's Navitor TAVI system granted CE Mark for expanded indication
1 September 2025 - US-based medical device and healthcare company Abbott (NYSE:ABT) announced on Friday that it has received CE Mark in Europe for an expanded indication for its Navitor transcatheter ...
PharmaResearch names VIVACY as European distribution partner for Rejuran
29 August 2025 - South Korea-based regenerative medicine company PharmaResearch announced on Thursday the signing of a strategic partnership agreement with VIVACY, a France-based global medical aesthe...
Airiver medical receives FDA approval for central airway stenosis trial
28 August 2025 - Airiver Medical, a clinical stage company developing technologies to help patients with certain respiratory tract conditions, said on Wednesday that it has received investigational de...